Sunday, May 28, 2017 5:47:33 PM
I guess you found the Sponsorship tab in the menu list in the top left corner of
https://biopharmadealmakers.nature.com/users/15958-nanoviricides/posts/15347-shaking-off-shingles-with-nanoviricides
It takes you to the page that includes the passage that you mentioned:
Contact Claire Thompson for details of how to become a BioPharma Dealmakers sponsor today.
Below that we see this:
For companies that want a presence on BioPharma Dealmakers primarily to network with potential partners, in the simplest way. Includes a company profile and full networking permissions to attract and explore dealmaking opportunities.
Networking permissions
Upvote content
Comment on content
Share content via social media
Follow individuals and companies
Be followed by individuals and companies
Take part in video panels
Send direct messages to individuals and companies
Invite individuals to join
See your company in the Companies > Networkers directory
View our Networker sponsors
That last line has a link in it that goes to:
https://biopharmadealmakers.nature.com/directory/organisations?group=networker
Go down the alphabetized list and I'll bet that you can guess who you'll find in the N's.
Here's something I'll bet will surprise the shareholders:
State of Ownership
Private
https://biopharmadealmakers.nature.com/users/15958-nanoviricides
I was given that information....I don't know.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM